ArticleCureus2025
A Case Report on Laryngeal Histoplasmosis Masquerading As Tuberculosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laryngeal histoplasmosis is a rare manifestation of infection by Histoplasma capsulatum, typically resulting from hematogenous dissemination following a primary pulmonary infection. However, primary laryngeal involvement without prior lung disease is uncommon and can present a diagnostic challenge. The disease often mimics laryngeal malignancies or other chronic inflammatory conditions due to its nonspecific symptoms, including progressive hoarseness, dysphagia, odynophagia, fatigue, malaise, and weight loss. Risk factors include immunosuppression, such as HIV/AIDS, prolonged corticosteroid use, or other conditions leading to impaired cellular immunity. Diagnosis requires a high index of suspicion, particularly in endemic regions, and is confirmed through histopathological examination, fungal cultures, or molecular testing of laryngeal biopsy specimens. Due to its rarity, misdiagnosis is common, leading to delays in appropriate antifungal therapy, which primarily consists of itraconazole or amphotericin B in severe cases. Early recognition and treatment are crucial to prevent complications and improve patient outcomes. This report highlights the need for increased awareness of laryngeal histoplasmosis among clinicians to facilitate timely diagnosis and management. We report the case of a 25-year-old male presented with dysphagia and increasing hoarseness of voice over three months, initially suspected to have tuberculosis (TB) but later diagnosed with primary laryngeal histoplasmosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.